A kind of dpp-4 inhibitor with piperazine structure

A technology of isomers and compounds, applied in the field of organic synthesis, can solve the problems of limited varieties of diabetes and inability to meet clinical needs, etc.

Active Publication Date: 2016-01-13
NANJING HUAWE MEDICINE TECH DEV
View PDF8 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, at present, there are limited varieties of drugs for the effective treatment of diabetes, which are far from meeting the clinical needs.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of dpp-4 inhibitor with piperazine structure
  • A kind of dpp-4 inhibitor with piperazine structure
  • A kind of dpp-4 inhibitor with piperazine structure

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0059] Chemical reaction formula:

[0060]

[0061] first step reaction

[0062] Weigh 6.63g of 2-aminopyrazine and 16.78g of ethyl 2-bromotrifluoromethyl acetate and mix them into a 250mL round bottom flask, measure 50mL of ethanol to dissolve and stir evenly, heat and stir at 95°C overnight. TLC detection (EA: MeOH = 20: 1, ammonia water) reaction process, after the raw materials are almost completely reacted, the sample is directly mixed and passed through the column to collect the product point (PE: EA = 20: 1 ~ 1: 1), concentrated to obtain intermediate 1 about 5.5 g, as light yellow solid, the yield is about 30%.

[0063] second step reaction

[0064] Measure about 100mL of MeOH to dissolve 5.5g of intermediate 1, add 1.1g of palladium carbon catalyst, replace with nitrogen three times and then replace with hydrogen three times, heat and stir at 30°C overnight, and seal under normal pressure for hydrogen protection. TLC detection (EA: MeOH = 20: 1, ammonia water) r...

Embodiment 2

[0073] The preparation of embodiment 2 compound 1-2

[0074] Chemical reaction formula:

[0075]

[0076] Dissolve 0.2g of intermediate 4 in 10ml of toluene, then add triphenylphosphine (1.5ep), dropwise add DEAD (1.5ep) under ice-water bath conditions, finally add 2.0ep methanol to the reaction solution, and then Stirring and reacting for 24 hours, TLC detection showed that the reaction of the raw materials was complete, and concentrated under reduced pressure. The obtained product was deprotected by methanol / concentrated hydrochloric acid to obtain about 100 mg of the target product I-2.

[0077] MS: 465[M+H],

[0078] H-NMR: δ7.44-7.35(m, 1H), 7.29-7.26(m, 1H), 5.19-5.06(m, 2H), 4.34-4.30(m, 1H), 4.12-4.02(m, 2H) , 3.94-3.84 (m, 5H), 3.20-2.89 (m, 2H), 2.83-2.81 (m, 2H).

Embodiment 3

[0079] The preparation of embodiment 3 compound I-7

[0080] Chemical reaction formula:

[0081]

[0082] Add 0.50 g of intermediate 4, 10 mL of DMF, 2.0 ep of triethylamine, 1.3 ep of HOBT and 1.5 ep of EDC·HCl into a 100 ml three-necked flask, stir at room temperature for 1 h, add 1.0 ep of methylamine in tetrahydrofuran, and react overnight at 31 ° C. TLC (DCM: MeOH=20:1, 2 drops of ammonia) tracked the completion of the reaction, the reaction solution was poured into 200ml of ice water, a large amount of white solid was precipitated, suction filtered, the filter cake was washed with water, and dried in vacuo at 45°C to obtain 0.55g of a gray solid. The obtained product was de-boc-protected to obtain compound I-7.

[0083] MS: 464[M+H],

[0084] H-NMR: δ7.43-7.35(m, 1H), 7.26-7.24(m, 1H), 5.18-5.06(m, 2H), 4.36-4.31(m, 1H), 4.16-4.02(m, 2H) , 3.97-3.92 (m, 2H), 3.24-2.87 (m, 2H), 2.87-2.82 (m, 2H), 2.75 (s, 3H).

[0085] Compound I-3, Compound I-4, and Compound I-5 wer...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a novel dipeptidyl peptidase IV (DPP-4) inhibitor namely a chemical compound shown in formula (I) with a piperazine structure. The chemical compound, and optical isomers and pharmaceutically acceptable salts of the chemical compound can be used for treating diabetes mellitus, especially non-insulin dependent diabetes mellitus and other diseases relative to DPP-4, wherein the definition of the substituent group X in the general formula (I) is the same as that in the specification.

Description

technical field [0001] The invention belongs to the field of organic synthesis, and specifically relates to a dipeptidyl peptidase IV (hereinafter referred to as DPP-4) inhibitor compound with a piperazine structure and its application for treating and preventing diabetes and other diseases related to DPP-4. Background technique [0002] Diabetes is a chronic metabolic disease caused by various pathogenic factors such as genetic factors, immune dysfunction, microbial infection and its toxins, free radical toxins, and mental factors. Clinically, it is characterized by hyperglycemia. Can be divided into type 1 diabetes (insulin-dependent), type 2 diabetes (non-insulin-dependent), gestational diabetes and other special types of diabetes. Type 2 diabetes accounts for about 95% of diabetic patients. [0003] At present, the main oral hypoglycemic agents are: sulfonylureas (SU), biguanides, α-glucosidase inhibitors, non-sulfonylurea insulin secretory drugs and insulin sensitizers...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): C07D487/04C07D519/00C07K5/078A61K31/4985A61K38/05A61P3/10
CPCA61K38/00C07D487/04C07D519/00C07K5/06139
Inventor 张孝清宋志春包金远蒋玉伟苏梅
Owner NANJING HUAWE MEDICINE TECH DEV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap